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this study is to report the measured body exposures treated 
with single dose intra-operative electron radiation therapy 
(IOERT) in a large cohort of patients and to analyze which 
beam parameters impact the body exposure. 
Materials and Methods: During an almost 5-year period, 
more than 500 Partial Breast Irradiation (PBI) procedures 
have been performed with IOERT in our institution for pT1N0 
unicentric ductal breast carcinoma. A dose of 21 Gy was 
prescribed at the 90% isodose depth. Beam delivery was 
achieved with a Mobetron 1000 (Intraop, Sunnyvale, Ca). This 
mobile accelerator produces 4, 6, 9 and 12 MeV electron 
Beams with a 10Gy/min dose rate. Although the Mobetron is 
self-shielded device, a small component of straight X-rays 
radiation is always present during treatment delivery. In 
order to measure their body exposure coming from this 
straight radiation, three LiF Thermo-Luminescent Dosimeters 
(TLD) were positioned on each patient, respectively on the 
thyroid, on the contralateral breast and at the gonads level. 
The TLD were placed in an Aluminum container thick enough 
to provide electronic equilibrium and to stop any scattered 
electrons. TLDs were directly read just after PBI in a manual 
Harshaw reader under Nitrogen flow. 
As a comparison, the body exposure in a series of 30 BCT 
patients treated with 6 MV external beams was measured in 
the same way.  
Results: Mean doses for PBI treatments on the thyroid, 
contralateral breast and gonads were 0.82, 0.41 and 0.14 cGy 
respectively. Higher energy beam gives significant higher 
body exposure. The field size, ranging from 35 mm to 65 mm 
does not influence the body exposure. On the other hand, the 
treated quadrant has an impact on measured doses. Patients 
treated with external radiation received much higher body 
doses, from 25 times to more than 100 times higher for the 
contralateral breast. 
Conclusions: As radiation protection is concerned, IOERT is a 
safe procedure and gives very small body doses, unlikely to 
increase the carcinogenetic risk significantly, especially in 
the contralateral breast. Pregnant women might, in certain 
circumstances and with additional safety measures, be 
treated with the IOERT approach with an acceptable fetal 
dose.  
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Purpose/Objective: To evaluate the necessity of using an 
image modality in order to improve and adapt the IORT 
dosimetry based on Monte Carlo simulations. 
Materials and Methods: A model of the Intrabeam™ system 
has been previously developed with the GATE platform taking 
into account the different parts of the device. This study was 
performed on 25 patients. A preoperative CT acquisition of 
the patient breast was performed and included in the 
simulation allowing accurate dose calculation (Figure 1).  
 
During IORT, in vivo dosimetry was performed on 15 patients 
using thermoluminescent dosimeters (TLD) placed on the skin 
at 1 and 3 cm around the spherical applicator. First, 
comparison between simulation results on GATE and TLD 
measurements have been performed to confirm the dose 
prediction at the TLD locations. The dose simulated was 
recorded at the same initial position of the TLD. The depth 
dose curves between MC simulations and software computed 
doses have been compared. Then, the dosimetric influence of 
the applicator’s position was simulated: the applicator has 
been moved from 5 mm to 10 mm around its initial position. 
Finally, in addition to pre-operative CT acquisition, an 
intraoperative CT has been acquired on three patients in 
order to validate the overall dosimetric evaluation protocol.  
Results: Patient results showed a good agreement between 
clinical experiments and simulations. Indeed the relative 
mean deviation between TLD and GATE dose measurements 
was 0.1% ± 0.11% with a maximum of 0.33%. The simulation 
uncertainty was less than 1% (from 0.41% to 0.95%). Breast 
densities significantly changed the depth dose curves 
compared to the one given by the Intrabeam software which 
consider the breast as homogeneous. Considering the 
applicator displacement, the mean percentage deviation of 
the dose was 6.3% ±44.9%, 8.8% ±89% at 5 mm and 10 mm 
respectively. These results indicated that the dosimetry was 
greatly influenced when moving the applicator position due 
to the high dose fall-off of the low energy x-ray source.  
Conclusions: We proposed the use of an accurate model of 
the Intrabeam system on the GATE platform accounting for 
the tissues heterogeneities. Using a pre-surgery image 
modality could greatly optimize the dosimetry by 
determining a better applicator position. The dosimetric 
evaluation of the proposed platform with patient datasets 
supports its use for patient specific dosimetry planning. By 
this way we should be able to adapt a personalized dosimetry 
and not also prescribe the same dose to all the patients.  
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Purpose/Objective: Intra-Operative Radiation Therapy with 
low energy X-rays (XIORT) is largely used for breast cancer 
treatment with spherical applicators [1]. However, only a 
few centers are involved in superficial intraoperative 
radiotherapy [2] and little information is available about the 
dose distributions of the INTRABEAM® (Carl Zeiss) obtained 
with these dedicated applicators. This study proposes a fast 
and precise method to calculate dose distribution from 
Monte-Carlo phase space data in the case of flat and surface 
applicators. 
Materials and Methods: We developed a strategy to 
determine realistic Phase Space Files (PSF) that reproduces 
the experimental dose distributions. On one hand, 
monoenergetic PSF and corresponding depth-dose profiles 
(PDD) are generated only once with a full Monte-Carlo 
simulation using with the penEasy [3] code, one for each 
energy up to 50 keV (computing time of a few CPU-days). 
These simulations include a detailed geometry of the device 
which describes the general features of the experimental 
dose of standard flat and surface applicators. These 
monochromatic PSF are binned and parameterized in terms 
of the relevant variables to make them easy to manipulate. 
On the other hand, we take the energy spectrum as a fitting 
function which is optimized by means of a genetic algorithm 
[4] to describe the experimental PDD of any applicator. 
Finally, the binned precomputed monoenergetic phase space 
files and the fitted energy spectrum are combined to build 
the actual PSF optimized to describe the dose distribution of 
the considered applicator. From the final optimized phase 
space file, the dose is computed either by penEasy or by an 
in-house analytical algorithm which takes into account 
condensed history simulations of both photoelectric and 
Compton interactions for X-rays up to 50 keV. We compared 
the computed dose distributions with measurements first in 
water, then in homogeneous and heterogeneous media (lung, 
bone, air). 
Results: Building the fitted PSF only takes a few minutes in a 
single core (i7@2.5 GHz). Dose distributions computed with 
the proposed strategy from the optimized PSF are in good 
agreement with the measurements performed at the Institut 
Universitaire du Cancer (Toulouse, France) with the flat and 
surface applicators. 
Conclusions: The dose calculation process presented in this 
work is fast, flexible and optimized to simple experimental 
data. This method is being implemented into Radiance® 
(GMV SA, Spain), a powerful IORT Treatment Planning System 
[5], for all INTRABEAM (Carl Zeiss) applicators and can be 
used for a wide range of clinical indications.  
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Purpose/Objective: Breast Conservation Therapy (BCT) is the 
'gold standard' in early-stage breast cancer treatment. Many 
BCT patients also require a boost to the tumor bed in 
addition to 3 to 5 weeks of external beam radiation 
treatment (EBRT). There are several different technologies 
that can be used to boost the tumor bed. This study reviews 
these various technologies, compares the volumes irradiated, 
the dose distributions to the tumor bed, and the overall 
homogeneity of the treatment, as well as the dose which is 
delivered to critical structures. The advantages and 
disadvantages of each boost approach are discussed. 
Materials and Methods: To simplify comparison in this study, 
we selected patients to evaluate who had a maximum tumor 
dimension of 2 cm at the time of the surgery. We selected 
patients with left-breasted tumors to maximize the impact of 
each technique on treating critical structures. For patients 
treated totally with EBRT, we selected patients who started 
EBRT no later than 6 weeks post-surgery. Both 3 and 5 week 
EBRT treatment schedules were studied. The TPS system and 
home-made software evaluated the dose distributions of the 
combined EBRT boost and EBRT whole breast treatment. For 
patients treated with IORT, the dose map was added to the 
EBRT distribution with a suitable registration. Estimated RBE 
corrections were made for the 50 kV devices. The α/β model 
was used to convert IORT doses to normal fractionated EBRT 
doses. 
Results: Three (3) patients treated with each technique were 
studied and the results were averaged to obtain the final 
data for each technique. Dose to critical structures were 
compared for all techniques knowing that the driving factor 
for dose to critical structures is the EBRT dose, not the boost 
dose. In theory, IORT with electrons had the most uniform 
dose over the smallest boost volume of all boost techniques 
but several parameters can influence the boost volume (50 
KV applicator diameter, presence of a chest wall shield, 
etc...) 
Conclusions: There are significant variations in the volumes 
and dose homogeneity of the irradiated boost volumes 
depending on which boost technique is used, but this does 
not appear to significantly impact the overall physical dose 
distributions when the EBRT dose is added to the boost. BED 
variations are somehow greater. There are, however, 
significant differences in advantages in one technique over 








PD-0571   
New genetic algorithm-based procedure to determine 
phase space for intraoperative radiation therapy 
P. Ibáñez1, M. Vidal1, R. García-Marcos1, P. Guerra2, J.M. 
Udías1 
1Universidad Complutense de Madrid CEI Moncloa, Física 
Atómica Molecular y Nuclear, Madrid, Spain  
